Press release: Raiffeisen sells majority of its stake in Leonteq

PRESS RELEASE | RAIFFEISEN SELLS MAJORITY OF ITS STAKE IN LEONTEQ

Zurich, 2 March 2026 | Ad-hoc announcement pursuant to Art. 53 LR

Leonteq AG has been informed by Raiffeisen Switzerland that it has sold a 22.7% stake in the company to H21 Macro Limited and four private investors, subject to customary regulatory approvals. The cooperation agreement with Raiffeisen is not affected and they retain a 7.0% in the stock.

Separately, FINMA has confirmed that Leonteq’s main operating subsidiary qualifies for bank-equivalent counterparty treatment going forward.

Leonteq has been informed by Raiffeisen Switzerland that it has sold a 22.7% stake in Leonteq AG. This includes the sale of 16.2% to H21 Macro Limited and a further 6.5% to four private investors. The transaction is subject to customary approvals by the relevant supervisory authorities and is expected to complete in the third quarter of 2026 at the latest.

Raiffeisen Switzerland will thus hold a stake of 7.0% in Leonteq. According to regulatory filings, Rainer Marc Frey is the beneficial owner of H21 Macro Limited and he held 7.1% in Leonteq shares as of 31 December 2025.

Raiffeisen has been a cooperation partner of Leonteq since 2013, and the cooperation agreement, which runs until 2030, is not affected by the sale of shares.

Christopher Chambers, Chairman of Leonteq, stated: “This transaction confirms that professional investors see clear value in Leonteq, and we also view it as a recognition of our progress in resolving legacy matters. In addition, we welcome the clarification regarding the stake of Raiffeisen and the increase in liquidity in our stock following the transaction. We look forward to continuing our business cooperation with Raiffeisen going forward.”

Bank-equivalent counterparty treatment for Leonteq Securities AG

Following the successful transition to the new regulatory regime, the Swiss Financial Market Supervisory Authority (FINMA) now also confirmed that Leonteq Securities AG can be assigned by counterparties to the position class “banks” under the Swiss Capital Adequacy Ordinance. This means that hedging counterparties and white-labelling partners will be able to risk-weight exposures to Leonteq in line with the treatment applicable to banks (rather than as exposures to a corporate counterparty, which are subject to higher risk-weighting charges).

Christian Spieler, CEO of Leonteq, stated: “We welcome this final step in the transition to the new regulatory framework. Together with our strong CET1-ratio of 16.9% at end-2025, the bank-equivalent treatment further enhances our risk and credit profile with counterparties. This reinforces our conviction that we are on the right track, and we remain fully focused on revenue growth and on reaching our 2026 guidance and mid-term goals.”

CONTACT
Media Relations 
+41 58 800 1844
media@leonteq.com 

Investor Relations 
+41 58 800 1855
investorrelations@leonteq.com

LEONTEQ

Leonteq is a Swiss fintech company with a leading marketplace for structured investment solutions. Based on proprietary modern technology, the company offers derivative investment products and services and predominantly covers the capital protection, yield enhancement and participation product classes. Leonteq acts as both a direct issuer of its own products and as a partner to other financial institutions. Leonteq further enables life insurance companies and banks to produce capital-efficient, unit-linked pension products with guarantees. The company has offices and subsidiaries in 13 countries across Europe, the Middle East and Asia. Leonteq Securities AG is the main operating subsidiary of Leonteq AG. The company is a securities firm regulated by the Swiss Financial Market Authority FINMA and was assigned a BBB-/stable credit-rating by Fitch Ratings. Leonteq AG is listed on the SIX Swiss Exchange (SIX: LEON) and was assigned with an AA ESG-rating by MSCI. www.leonteq.com

DISCLAIMER

This press release issued by Leonteq AG (the “Company”) serves for information purposes only and does not constitute research. This press release and all materials, documents and information used therein or distributed in the context of this press release do not constitute or form part of and should not be construed as, an offer (public or private) to sell or a solicitation of offers (public or private) to purchase or subscribe for shares or other securities of the Company or any of its affiliates or subsidiaries in any jurisdiction or an inducement to enter into investment activity in any jurisdiction, and may not be used for such purposes. Copies of this press release may not be made available (directly or indirectly) to any person in relation to whom the making available of the press release is restricted or prohibited by law or sent to countries, or distributed in or from countries, to, in or from which this is restricted or prohibited by law.

This press release may contain specific forward-looking statements, e.g. statements including terms like “believe“, “assume“, “expect“, "target" “forecast“, “project“, “may“, “could“, “might“, “will“ or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the Company or any of its affiliates or subsidiaries and those explicitly or implicitly presumed in these statements. These factors include, but are not limited to: (1) general market, macroeconomic, governmental and regulatory trends, (2) movements in securities markets, exchange rates and interest rates and (3) other risks and uncertainties inherent in our business. Against the background of these uncertainties, you should not rely on forward-looking statements. Neither the Company nor any of its affiliates or subsidiaries or their respective bodies, executives, employees and advisers assume any responsibility to prepare or disseminate any supplement, amendment, update or revision to any of the information, opinions or forward-looking statements contained in this press release or to adapt them to any change in events, conditions or circumstances, except as required by applicable law or regulation.